Once Upon a Farm, PBC
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
OFRM$10.02-1.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(In thousands)
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| OPERATING ACTIVITIES | ||
| Net loss | $(15,811) | $(19,466) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Change in fair value of derivative liability | (340) | 9,680 |
| Change in fair value of convertible preferred stock warrant liability | (13) | 464 |
| Change in fair value of SARs liability | (2) | — |
| Stock-based compensation | 4,338 | 805 |
| SARs issued to a customer recorded as a reduction to revenue | 43 | — |
| Inventory adjustments | 622 | 189 |
| Depreciation and amortization | 475 | 257 |
| Amortization of debt discounts and deferred financing costs | 49 | 138 |
| Non-cash interest | 29 | 147 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (5,780) | (4,371) |
| Inventory | (3,910) | (6,532) |
| Prepaid expenses and other assets | (3,936) | (2,326) |
| Accounts payable | (743) | 4,055 |
| Accrued expenses and other liabilities | 12,139 | 2,484 |
| Net cash used in operating activities | (12,840) | (14,476) |
| INVESTING ACTIVITIES | ||
| Purchase of property and equipment | (1,446) | (450) |
| Net cash used in investing activities | (1,446) | (450) |
| FINANCING ACTIVITIES | ||
| Proceeds from issuance of common stock | 155,366 | — |
| Proceeds from term loan facility | — | 14,000 |
| Proceeds from exercise of stock options | 17 | 127 |
| Payment of debt modification costs | — | (34) |
| Repayment of line of credit | (43,000) | — |
| Payment of offering costs | (9,071) | — |
| Payment of deferred offering costs | — | (104) |
| Net cash provided by financing activities | 103,312 | 13,989 |
| Net change in cash and cash equivalents | 89,026 | (937) |
| Cash and cash equivalents, beginning of period | 10,860 | 17,306 |
| Cash and cash equivalents, end of period | $99,886 | $16,369 |
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | ||
| Cash paid for interest | $342 | $234 |
| Cash paid for income taxes | $— | $3 |
| SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES | ||
| Capital expenditures included in accounts payable and accrued expenses | $697 | $55 |
| Offering costs included in accounts payable and accrued expenses | $248 | $— |
| Deferred offering costs included in accounts payable and accrued expenses | $— | $336 |
| Deferred offering costs transferred to additional paid in capital | $13,987 | $— |
| Conversion of convertible preferred stock to common stock | $101,967 | $— |
| Conversion of convertible notes to equity | $18,678 | $— |
| Reclassification of derivative liability to equity | $32,073 | $— |
| Issuance of common stock upon net exercise of warrants | $1,871 | $— |
The accompanying notes are an integral part of these Unaudited Condensed Financial Statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.